- Home
- ADCT vs NFGC Comparison
ADCT vs NFGC Comparison
Compare ADCT & NFGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- NFGC
- Stock Information
- Founded
- ADCT 2011
- NFGC 2016
- Country
- ADCT Switzerland
- NFGC Canada
- Employees
- ADCT N/A
- NFGC N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- NFGC Precious Metals
- Sector
- ADCT Health Care
- NFGC Basic Materials
- Exchange
- ADCT Nasdaq
- NFGC Nasdaq
- Market Cap
- ADCT 398.2M
- NFGC 364.6M
- IPO Year
- ADCT 2020
- NFGC N/A
- Fundamental
- Price
- ADCT $3.25
- NFGC $1.95
- Analyst Decision
- ADCT Strong Buy
- NFGC Strong Buy
- Analyst Count
- ADCT 6
- NFGC 1
- Target Price
- ADCT $7.80
- NFGC $5.00
- AVG Volume (30 Days)
- ADCT 545.2K
- NFGC 1.4M
- Earning Date
- ADCT 11-06-2025
- NFGC 11-11-2025
- Dividend Yield
- ADCT N/A
- NFGC N/A
- EPS Growth
- ADCT N/A
- NFGC N/A
- EPS
- ADCT N/A
- NFGC N/A
- Revenue
- ADCT $77,246,000.00
- NFGC N/A
- Revenue This Year
- ADCT $13.10
- NFGC N/A
- Revenue Next Year
- ADCT $6.23
- NFGC N/A
- P/E Ratio
- ADCT N/A
- NFGC N/A
- Revenue Growth
- ADCT 15.73
- NFGC N/A
- 52 Week Low
- ADCT $1.05
- NFGC $0.93
- 52 Week High
- ADCT $3.97
- NFGC $2.89
- Technical
- Relative Strength Index (RSI)
- ADCT 51.93
- NFGC 55.80
- Support Level
- ADCT $3.15
- NFGC $1.78
- Resistance Level
- ADCT $3.38
- NFGC $2.19
- Average True Range (ATR)
- ADCT 0.18
- NFGC 0.13
- MACD
- ADCT -0.02
- NFGC -0.00
- Stochastic Oscillator
- ADCT 38.53
- NFGC 45.35
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About NFGC New Found Gold Corp
New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Company's exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).